|Bid||2.9800 x 3100|
|Ask||3.0000 x 1000|
|Day's Range||2.9800 - 3.0000|
|52 Week Range||1.6100 - 3.6600|
|Beta (3Y Monthly)||1.35|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 6, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.50|
NEW YORK , Nov. 22, 2019 /PRNewswire/ -- Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City , is investigating potential claims involving the directors and officers ...
WILMINGTON, Del., Nov. 18, 2019 -- Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of.
Arotech (ARTX) delivered earnings and revenue surprises of 0.00% and -10.87%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
ANN ARBOR, Mich., Nov. 06, 2019 -- Arotech Corporation (NasdaqGM: ARTX) today announced financial results for the quarter and nine months ended September 30, 2019. Third.
NEW YORK, Nov. 01, 2019 -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Fibrocell Science, Inc. (NASDAQ: FCSC)The.
Arotech (ARTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ANN ARBOR, Mich., Oct. 23, 2019 -- Arotech Corporation (NasdaqGM: ARTX) a provider of quality defense and security products for the military, law enforcement and homeland.
BALA CYNWYD, PA / ACCESSWIRE / October 17, 2019 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Arotech Corporation ("Arotech" ...
WILMINGTON, Del., Oct. 17, 2019 -- Rigrodsky & Long, P.A. announces that it is investigating: Progenics Pharmaceuticals, Inc. (NASDAQ GS: PGNX) regarding possible breaches.
NEW YORK , Oct. 8, 2019 /PRNewswire/ -- Arotech Corporation (ARTX) Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the sale of Arotech to Greenbriar ...
KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (email@example.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgm-artx/ to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.
NEW YORK, NY / ACCESSWIRE / September 24, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in ...
NEW YORK, Sept. 24, 2019 -- Halper Sadeh LLP, a global investor rights law firm, is investigating the following companies: Proteon Therapeutics, Inc. (NASDAQ: PRTO) The.
WILMINGTON, DE / ACCESSWIRE / September 24, 2019 / Rigrodsky & Long, P.A.: Do you own shares of Arotech Corporation (NASDAQ GS: ARTX )? Did you purchase any of your shares prior to September 23, 2019? ...
NEW YORK, Sept. 23, 2019 /PRNewswire/ -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Arotech Corporation (ARTX) on behalf of Arotech shareholders concerning the proposed merger with an affiliate of Greenbriar Equity Group, L.P. Pursuant to the proposed transaction, announced on September 23, 2019 and valued at $80.3 million, Arotech shareholders will receive $3 in cash for each share of Arotech common stock owned. The investigation focuses on whether Arotech and its board of directors violated the federal securities laws and/or breached their fiduciary duties to the Company's shareholders by failing to conduct a fair process and whether and by how much the proposed transaction undervalues the Company. If you own Arotech shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Alexandra Raymond by email at firstname.lastname@example.org, or by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
NEW YORK , Sept. 23, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Arotech Corporation ("Arotech" or the ...
Shares of Arotech Corp. rocketed 30.5% to pace all Nasdaq gainers on heavy volume in afternoon trading Monday, after the defense and security company agreed to be acquired by an affiliate of Greenbriar Equity Group L.P. in a deal valued at $80.8 million. Trading volume swelled to 10.4 million shares, compared with the full-day average of about 236,000 shares. Under terms of the deal, Arotech shareholders will get $3 for each Arotech share they own, a 33% premium to Friday's closing price of $2.26. The deal is expected to close during the first quarter of 2020. The stock has now gained 12.6% year to date, while the S&P 500 has advanced 19.5%.
NEW YORK, Sept. 23, 2019 -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Arotech Corporation (“Arotech” or.
Arotech Corporation (ARTX) today announced that it has entered into a definitive agreement with an affiliate of Greenbriar Equity Group, L.P. (“Greenbriar”) under which the affiliate will acquire all outstanding shares of Arotech common stock for $3.00 per share in cash, representing an aggregate equity value of approximately $80.8 million. The $3.00 per share cash consideration represents a premium of approximately 32.7% to Arotech’s closing share price on September 20, 2019, the last full trading day before today’s announcement. The transaction, which was unanimously approved by Arotech’s Board of Directors upon recommendation by a Special Committee of the Board, is expected to close in the first quarter of 2020.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Today we are going to look at Arotech Corporation (NASDAQ:ARTX) to see whether it might be an attractive investment...
Dean Krutty became the CEO of Arotech Corporation (NASDAQ:ARTX) in 2017. This analysis aims first to contrast CEO...
Arotech (ARTX) delivered earnings and revenue surprises of 200.00% and 7.82%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?